Dexamethasone suppression test in patients with Parkinson's disease
- 1 January 1990
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 5 (1) , 23-26
- https://doi.org/10.1002/mds.870050106
Abstract
The Dexamethasone Suppression Test (DST), supposed to effectively distinguish between endogenous and nonendogenous depression, was performed in a group of 34 patients with Parkinson's disease. Abnormal DST results were observed in 50% of the patients. The patients were clinically divided into subgroups of depressed and nondepressed parkinsonians. Abnormal DST results were significantly more frequent in depressed (75%) than in nondepressed parkinsonians (27.7%).Keywords
This publication has 28 references indexed in Scilit:
- Depression in Parkinson's disease: a quantitative and qualitative analysis.Journal of Neurology, Neurosurgery & Psychiatry, 1986
- PARKINSON'S DISEASE AND DEPRESSIONBrain, 1986
- The Dexamethasone Suppression TestArchives of Neurology, 1985
- Altered serotonin metabolism in depressed patients with Parkinson's diseaseNeurology, 1984
- The dexamethasone suppression test: Clinical applicationsPsychosomatics, 1981
- Depression, intellectual impairment, and Parkinson diseaseNeurology, 1981
- Evidence to support early levodopa therapy in Parkinson diseaseNeurology, 1981
- A Specific Laboratory Test for the Diagnosis of MelancholiaArchives of General Psychiatry, 1981
- Neuroendocrine Regulation in DepressionArchives of General Psychiatry, 1976
- Parkinsonism and DepressionSouthern Medical Journal, 1972